Single-dose,First-in-human of KLA478

NCT07240675 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: pramipexole hydrochloride sustained-release tablets
DRUG: KLA478
DRUG: placebo

Sponsor

Hunan Kelun Pharmaceutical Co., Ltd.